Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Flower One Holdings

CNSX:FONE
Snowflake Description

Very undervalued with reasonable growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FONE
CNSX
CA$129M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. The last earnings update was 88 days ago. More info.


Add to Portfolio Compare Print
  • Flower One Holdings has significant price volatility in the past 3 months.
FONE Share Price and Events
7 Day Returns
1.5%
CNSX:FONE
-1.8%
CA Pharmaceuticals
0.2%
CA Market
1 Year Returns
-70.1%
CNSX:FONE
-59.2%
CA Pharmaceuticals
4.6%
CA Market
FONE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Flower One Holdings (FONE) 1.5% -13.8% -27.4% -70.1% - -
CA Pharmaceuticals -1.8% -13.9% -10.4% -59.2% 14.7% 327.1%
CA Market 0.2% 0.5% 4% 4.6% 7.2% 14.2%
1 Year Return vs Industry and Market
  • FONE underperformed the Pharmaceuticals industry which returned -59.2% over the past year.
  • FONE underperformed the Market in Canada which returned 4.6% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

FONE Value

 Is Flower One Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Flower One Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Flower One Holdings.

CNSX:FONE Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:FONE
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.4%
Equity Risk Premium S&P Global 5.4%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.69
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.685 (1 + (1- 26.5%) (94.88%))
1.109
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.11
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.44% + (1.109 * 5.44%)
7.47%

Discounted Cash Flow Calculation for CNSX:FONE using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Flower One Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:FONE DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.47%)
2020 33.19 Analyst x1 30.88
2021 40.28 Analyst x1 34.87
2022 60.83 Analyst x1 49.00
2023 74.24 Est @ 22.06% 55.65
2024 86.03 Est @ 15.87% 60.00
2025 95.96 Est @ 11.54% 62.27
2026 104.12 Est @ 8.51% 62.87
2027 110.78 Est @ 6.39% 62.24
2028 116.21 Est @ 4.91% 60.75
2029 120.71 Est @ 3.87% 58.71
Present value of next 10 years cash flows $537.00
CNSX:FONE DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $120.71 × (1 + 1.44%) ÷ (7.47% – 1.44%)
$2,029.39
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $2,029.39 ÷ (1 + 7.47%)10
$987.07
CNSX:FONE Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $537.00 + $987.07
$1,524.07
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,524.07 / 187.42
$8.13
CNSX:FONE Discount to Share Price
Calculation Result
Exchange Rate USD/CAD
(Reporting currency to currency of CNSX:FONE)
1.321
Value per Share
(CAD)
= Value per Share in USD x Exchange Rate (USD/CAD)
= $8.13 x 1.321
CA$10.75
Value per share (CAD) From above. CA$10.75
Current discount Discount to share price of CA$0.69
= -1 x (CA$0.69 - CA$10.75) / CA$10.75
93.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Flower One Holdings is available for.
Intrinsic value
>50%
Share price is CA$0.69 vs Future cash flow value of CA$10.75
Current Discount Checks
For Flower One Holdings to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Flower One Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Flower One Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Flower One Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Flower One Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:FONE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.17
CNSX:FONE Share Price ** CNSX (2020-02-21) in CAD CA$0.69
CNSX:FONE Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.757 $0.52
Canada Pharmaceuticals Industry PE Ratio Median Figure of 11 Publicly-Listed Pharmaceuticals Companies 16.05x
Canada Market PE Ratio Median Figure of 510 Publicly-Listed Companies 16.18x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Flower One Holdings.

CNSX:FONE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:FONE Share Price ÷ EPS (both in USD)

= 0.52 ÷ 0.17

3x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Flower One Holdings is good value based on earnings compared to the CA Pharmaceuticals industry average.
  • Flower One Holdings is good value based on earnings compared to the Canada market.
Price based on expected Growth
Does Flower One Holdings's expected growth come at a high price?
Raw Data
CNSX:FONE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 3x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
12.6%per year
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 6 Publicly-Listed Pharmaceuticals Companies 1.55x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 1.13x

*Line of best fit is calculated by linear regression .

CNSX:FONE PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 3x ÷ 12.6%

0.24x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Flower One Holdings is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Flower One Holdings's assets?
Raw Data
CNSX:FONE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $0.64
CNSX:FONE Share Price * CNSX (2020-02-21) in CAD CA$0.69
CNSX:FONE Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.757 $0.52
Canada Pharmaceuticals Industry PB Ratio Median Figure of 154 Publicly-Listed Pharmaceuticals Companies 1.5x
Canada Market PB Ratio Median Figure of 2,342 Publicly-Listed Companies 1.4x
CNSX:FONE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:FONE Share Price ÷ Book Value per Share (both in USD)

= 0.52 ÷ 0.64

0.81x

* Primary Listing of Flower One Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Flower One Holdings is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Flower One Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Flower One Holdings has a total score of 6/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FONE Future Performance

 How is Flower One Holdings expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Flower One Holdings expected to grow at an attractive rate?
  • Flower One Holdings's earnings growth is expected to exceed the low risk savings rate of 1.4%.
Growth vs Market Checks
  • Flower One Holdings's earnings growth is expected to exceed the Canada market average.
  • Flower One Holdings's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:FONE Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:FONE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 12.6%
CNSX:FONE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 52.8%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 69.1%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 40.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 10.9%
Canada Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:FONE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:FONE Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 224 1
2022-12-31 202 64 1
2021-12-31 170 58 44 5
2020-12-31 104 28 1 5
2020-02-22
2019-12-31 9 -40 26 5
CNSX:FONE Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 4 -23 31
2019-06-30 1 -17 10
2019-03-31 1 -12 -10
2018-12-31 0 -5 -12

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Flower One Holdings's earnings are expected to grow by 12.6% yearly, however this is not considered high growth (20% yearly).
  • Flower One Holdings's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:FONE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from Flower One Holdings Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:FONE Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.21 0.21 0.21 1.00
2020-12-31 0.00 0.00 0.00 1.00
2020-02-22
2019-12-31 0.14 0.14 0.14 1.00
CNSX:FONE Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 0.17
2019-06-30 0.06
2019-03-31 -0.06
2018-12-31 -0.09

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Flower One Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Flower One Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Flower One Holdings has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FONE Past Performance

  How has Flower One Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Flower One Holdings's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Unable to establish if Flower One Holdings's year on year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
  • Unable to compare Flower One Holdings's 1-year earnings growth to the 5-year average as it has been trading publicly for less than 3 years.
  • Flower One Holdings has been loss making too recently or no data is available, we can't compare it to the CA Pharmaceuticals industry average.
Earnings and Revenue History
Flower One Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Flower One Holdings Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:FONE Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 3.80 31.12 19.79
2019-06-30 1.30 9.86 15.79
2019-03-31 0.67 -10.31 12.51
2018-12-31 0.13 -12.45 8.29

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Flower One Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Flower One Holdings used its assets more efficiently than the CA Pharmaceuticals industry average last year based on Return on Assets.
  • Unable to establish if Flower One Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess Flower One Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Flower One Holdings has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FONE Health

 How is Flower One Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Flower One Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Flower One Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Flower One Holdings's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Flower One Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Flower One Holdings Company Filings, last reported 4 months ago.

CNSX:FONE Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 116.32 71.62 5.56
2019-06-30 97.89 44.91 0.60
2019-03-31 71.61 33.66 5.72
2018-12-31 68.58 32.08 2.59
  • Flower One Holdings's level of debt (61.6%) compared to net worth is high (greater than 40%).
  • Unable to establish if Flower One Holdings's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 11.2x coverage).
X
Financial health checks
We assess Flower One Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Flower One Holdings has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FONE Dividends

 What is Flower One Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Flower One Holdings dividends.
If you bought CA$2,000 of Flower One Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Flower One Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Flower One Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:FONE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 2.7%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:FONE Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2020-02-22
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Flower One Holdings has not reported any payouts.
  • Unable to verify if Flower One Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Flower One Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Flower One Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Flower One Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Flower One Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Flower One Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FONE Management

 What is the CEO of Flower One Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ken Villazor
COMPENSATION $396,250
AGE 50
TENURE AS CEO 2.1 years
CEO Bio

Mr. Ken Villazor serves as President, Chief Executive Officer and Director of Flower One Holdings Inc January 2018. Mr. Villazor serves as an Independent Director at Organic Garage Ltd. since 2016. He has worked for Senators Sports & Entertainment since August 2003 serving principally as an Adviser to the Owner, Chairman and Chief Executive Officer of the National Hockey League's Ottawa Senators. Mr. Villazor has more than 20 years of experience in Corporate Affairs including communications, public relations, business development, regulatory affairs, government relations, philanthropy and public policy. He has held numerous senior positions in the pharmaceutical industry working extensively in government regulated aspects of commercial operations including formulary/market access, pricing compliance, price controls, manufacturing grants, regulatory approvals and shaping federal and provincial government policies. He has worked for a number of large pharmaceutical companies including SmithKline Beecham, GlaxoSmithKline and Biovail Corporation as well as with the industry’s national trade association based in Ottawa. In addition, Mr. Villazor also spent more than decade in the sports and entertainment industry including having served as an Alternate Governor to a National Hockey League franchise. Mr. Villazor is also a member of the development group selected as the highest ranked proponent by the National Capital Commission to redevelop the 53 acre LeBreton Flats site in downtown Ottawa. Mr. Villazor sits on the Board of Directors of the Ottawa Senators Foundation. His board experience spans the academic sector, not-for-profit sector and publicly-traded companies. Mr. Villazor holds a Bachelor of Science (Hon) degree from St. Michael's College at the University of Toronto.

CEO Compensation
  • Insufficient data for Ken to compare compensation growth.
  • Ken's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Flower One Holdings management team in years:

1.7
Average Tenure
41
Average Age
  • The average tenure for the Flower One Holdings management team is less than 2 years, this suggests a new team.
Management Team

Ken Villazor

TITLE
President
COMPENSATION
$396K
AGE
50
TENURE
2.1 yrs

Geoff Miachika

TITLE
Chief Financial Officer
COMPENSATION
$674K
AGE
37
TENURE
1.7 yrs

Jean Martin

TITLE
Corporate Secretary
COMPENSATION
$140K
AGE
45

Kellen O'Keefe

TITLE
Chief Strategy Officer
AGE
36
TENURE
0.6 yrs
Board of Directors Tenure

Average tenure and age of the Flower One Holdings board of directors in years:

1.9
Average Tenure
48
Average Age
  • The average tenure for the Flower One Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ken Villazor

TITLE
President
COMPENSATION
$396K
AGE
50
TENURE
2.1 yrs

Amit Varma

TITLE
Non-Executive Director
COMPENSATION
$392K
AGE
36
TENURE
1.9 yrs

David Wesley

TITLE
Non-Executive Director
COMPENSATION
$392K
AGE
46
TENURE
1.9 yrs

Molly Hemmeter

TITLE
Director
AGE
52
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Flower One Holdings individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
04. Dec 19 Buy Geoffrey Miachika Individual 03. Dec 19 03. Dec 19 5,500 CA$0.76 CA$4,180
20. Nov 19 Sell Yaletown Family Trust Company 20. Jun 19 20. Jun 19 -10,000 CA$3.00 CA$-30,000
20. Nov 19 Sell Southlands Family Trust Company 20. Jun 19 20. Jun 19 -10,000 CA$3.00 CA$-30,000
02. Jun 19 Buy Geoffrey Miachika Individual 31. May 19 31. May 19 2,000 CA$2.71 CA$5,420
18. Mar 19 Buy Amit Varma Individual 14. Mar 19 14. Mar 19 5,882 CA$2.55 CA$14,999
01. May 19 Buy Amit Varma Individual 01. May 19 01. May 19 2,353 CA$3.08 CA$7,247
25. Apr 19 Sell Karl Fox Individual 15. Apr 19 25. Apr 19 -71,138 CA$3.54 CA$-234,971
23. Apr 19 Sell Karl Fox Individual 16. Mar 19 25. Mar 19 -22,600 CA$3.20 CA$-66,868
09. Oct 19 Sell Karl Fox Individual 09. Oct 19 09. Oct 19 -21,000 CA$1.44 CA$-30,198
26. Sep 19 Sell Karl Fox Individual 26. Sep 19 26. Sep 19 -2,300 CA$1.72 CA$-3,956
X
Management checks
We assess Flower One Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Flower One Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FONE News

Simply Wall St News

FONE Company Info

Description

Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates a 25,000 square foot indoor cultivation and production facility in North Las Vegas with 9 grow rooms; and 455,000 square-foot greenhouse and production facility in Nevada. The company offers NLV Organics consumer brand of cannabis products; and cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products. It also focuses on the resale and wholesale of cannabis products and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.

Details
Name: Flower One Holdings Inc.
FONE
Exchange: CNSX
Founded:
CA$129,320,022
187,420,323
Website: http://www.flowerone.com
Address: Flower One Holdings Inc.
20 Richmond Street West,
Suite 600,
Toronto,
Ontario, M5C 2R9,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX FONE Common Shares Canadian National Stock Exchange CA CAD 10. Oct 2018
OTCPK FLOO.F Common Shares Pink Sheets LLC US USD 10. Oct 2018
Number of employees
Current staff
Staff numbers
38
Flower One Holdings employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/22 03:15
End of day share price update: 2020/02/21 00:00
Last estimates confirmation: 2019/12/18
Last earnings filing: 2019/11/26
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.